Corteva, Inari settle US dispute over seed patents during trial

By Reuters News

By Blake Brittain

Sept 28 (Reuters) - Agricultural technology giant Corteva Agriscience CTVA.N has settled a lawsuit accusing startup rival Inari Agriculture of illegally obtaining and copying its patented corn and soybean seeds, the companies said in a filing in Delaware federal court.

  • The companies resolved the case days into a trial in Delaware that had started on September 23

  • Corteva and Inari asked the court late Sunday to dismiss the case with prejudice, which means it cannot be refiled

  • The filing did not disclose financial terms of the settlement but said that Inari would destroy all Corteva seeds and other biological materials in its possession

  • Spokespeople for the companies did not immediately respond to requests for comment or for more information about the settlement on Monday

  • Corteva sued Inari in 2023

  • Inari denied the allegations and argued the patents were invalid

  • Corteva spun off from DowDuPont in 2019

The case is Corteva Agriscience LLC v. Inari Agriculture Inc, US District Court for the District of Delaware, No. 1:23-cv-01059.

For Corteva: Peter Bicks of Orrick Herrington & Sutcliffe

For Inari: Dimitrios Drivas of White & Case

Read more:

Corteva competitor Inari must face seed patent lawsuit

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.